An Overview of the 2020 American College of Cardiology Expert Consensus Decision Pathway on Novel Therapies for CV Risk Reduction in Patients With T2D

Guest: Joshua Stolker, MD <br> <p>The 2020 American College of Cardiology Expert Consensus Decision Pathway provides a change in mindset for the cardiology field when it comes to treating patients with type 2 diabetes with established cardiovascular disease. Here to walk us through these updated recommendations is Dr. Joshua Stolker, an interventional cardiologist at Mercy Clinic Heart and Vascular in Saint Louis, Missouri.</p> <p>To view the 2020 American College of Cardiology Expert Consensus Decision Pathway click <span style="text-decoration: underline;"><a href="https://www.jacc.org/doi/10.1016/j.jacc.2020.05.037?_ga=2.65987374.1642602798.1611941474-440573254.1611941474&amp;">here</a></span>.</p> <p>Novo Nordisk is a registered trademark of Novo Nordisk A/S.</p> <p>© 2021 Novo Nordisk All rights reserved. US20DI00430 January 2021</p>